See All Slides - tctmd.com

Slides

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

Overview of Paravalvular Leak Closure and Outcomes

Presenter: Chet Rihal

October 31, 2013

Presentation TCT 2013

Renal Denervation with the St. Jude EnligHTN Device: One Simple and One Not-So-Simple Case

Presenter: Felix Mahfoud

October 31, 2013

Presentation TCT 2013

GIANT: A Prospective Registry Study of CYP2C19 Genetic Profiling for Thienopyridine Management After Primary PCI in Acute Myocardial Infarction

Presenter: Bernard Chevalier

October 31, 2013

Presentation TCT 2013

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Presenter: Praveen Chandra

October 31, 2013

Presentation TCT 2013

Interventional Management of Cardiogenic Stroke

Presenter: Robert Sommer

October 31, 2013

Presentation TCT 2013

Introduction and AHA Policy Statement

Presenter: H. Robert Superko

October 31, 2013

Presentation TCT 2013

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Presenter: Eugenia Nikolsky

October 31, 2013

Presentation TCT 2013

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Presenter: James Devlin

October 31, 2013

Presentation TCT 2013

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

Presenter: Jeffrey Moses

October 31, 2013

Advertisement

Slides

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Overview of Paravalvular Leak Closure and Outcomes

Renal Denervation with the St. Jude EnligHTN Device: One Simple and One Not-So-Simple Case

GIANT: A Prospective Registry Study of CYP2C19 Genetic Profiling for Thienopyridine Management After Primary PCI in Acute Myocardial Infarction

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Interventional Management of Cardiogenic Stroke

Introduction and AHA Policy Statement

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content